Apotea AB (publ) (FRA:V30) ROCE %: 36.02% (As of Mar. 2026)


FRA:V30 Apotea AB (publ) FRA:V30
19 GF Score
Price €6.84
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) ROCE %?

Apotea AB (publ) FRA:V30 +1.33% 19 ROCE % is 36.02% as of Mar. 2026. GuruFocus rates FRA:V30 with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Apotea AB (publ)'s annualized ROCE % for the quarter that ended in Mar. 2026 was 36.02%.

Apotea AB (publ)  (FRA:V30) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Apotea AB (publ) ROCE % Related Terms

Apotea AB (publ) ROCE % Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) ROCE % Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
28.75 6.72 20.14 40.21 33.24

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.88 37.74 33.25 9.14 36.02
FRA:V30
19GF Score
Apotea AB (publ) FRA:V30
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) ROCE % Calculation

Apotea AB (publ)'s annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=27.733/( ( (141.507 - 76.574) + (181.992 - 80.084) )/ 2 )
=27.733/( (64.933+101.908)/ 2 )
=27.733/83.4205
=33.24 %

Apotea AB (publ)'s ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=37.988/( ( (181.992 - 80.084) + (206.177 - 97.175) )/ 2 )
=37.988/( ( 101.908 + 109.002 )/ 2 )
=37.988/105.455
=36.02 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 36.02% mean?
Apotea AB (publ) (FRA:V30) has a ROCE % of 36.02% as of Mar. 2026.
Is Apotea AB (publ)'s ROCE % too high?
Apotea AB (publ)'s current ROCE % is 36.02%. The Healthcare Providers & Services industry median ROCE % is 6.41. Apotea AB (publ)'s value of 36.02% is 461.9% above this industry median. Overall, Apotea AB (publ) has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s ROCE % compare to competitors?
Apotea AB (publ)'s ROCE % of 36.02% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Apotea AB (publ)'s value of 36.02% is 461.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 644 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current ROCE % of 36.02% is 461.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current ROCE % is 36.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (FRA:V30) has a current ROCE % of 36.02%. The current ROCE % is 36.02% and 461.9% above the Healthcare Providers & Services industry median of 6.41. Apotea AB (publ)'s overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Apotea AB (publ) (FRA:V30), the current ROCE % is 36.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
19GF Score

Get the complete analysis for FRA:V30

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.84
Price